Intellectual Property News & Topics - Secerna LLP

WAKIX (1)

A to Z: Drugs in Highlight: W is for WAKIX®

News A to Z Feature 08/05/2025

Our A to Z series highlights WAKIX® (from Bioprojet Pharma) which is used to treat narcolepsy in adults, adolescents and children from 6 years of age. The active substance in WAKIX® is pitolisant. Pitolisant works by blocking histamine from attaching to the histamine H3 receptor on nerve cells.

Read more

Mrna Vaccines (1)

News 07/02/2024

Breaking Down the Code: Demystifying the Patent Battles Behind mRNA Vaccines

Ireland UPC

European, News, UPC 02/02/2024

Ireland to Vote on Joining the Unified Patent Court in June 2024

Matthew Feuer Image

Team news, Careers 30/01/2024

Matthew Feuer in profile

Secerna Office

News 29/01/2024

Join Secerna's Chemistry & Pharma Team as a Finalist/Newly Qualified Patent Attorney

Plant Baserd Meat

News 23/01/2024

Sustainability Through Innovation: IP Strategies for Meat Alternatives

Secerna Website Images 2023 (35)

Industry news, News 19/01/2024

Apple Watch Series 9 & Ultra 2 Grounded in US: Blood Oxygen Patent Dispute Takes Flight

Georgia EPO

European, Industry news, News 15/01/2024

New Route to Patent Protection in Georgia: European Applications Now Validated

Secerna Website Images 2023 (33)

Industry news, News 11/01/2024

Why AI-Generated Patent Applications Can Put Your Innovation at Risk

Protect Patent Portfolio

Industry news, News 02/01/2024

Patent Portfolio Management: The Key to Protecting Innovation

10 11 12 13 14 15 16 17 18 19 20